Novel human phosphorylase kinase gamma subunit
CA 2264545 A1 · Owner: Incyte Genomics, Inc. · Inventors: Goli, Surya K.; Bandman, Olga
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a novel human phosphorylase kinase gamma subunit (HPHKG) and the polynucleotide which identifies and encodes HPHKG. The invention provides for expression vectors and host cells comprising the nucleic acid sequence encoding HPHKG. The invention also provides pharmaceutical compositions containing purified HPHKG or antisense molecules to HPHKG for the treatment of diseases associated with expression of HPHKG. The invention also includes diagnostic compositions containing the polynucleotide, fragments or the complement thereof which hybridize with the , genomic sequence or the transcript of polynucleotides encoding HPHKG or anti- HPHKG antibodies which …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 30, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 30, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 30, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.